Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: Helping Hypertensive Latinos to Improve Medication Adherence [NA]
A completed clinical trial update evaluating strategies to improve medication adherence in hypertensive Latino patients.
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: Community-based Microalbuminuria Screening in Patients With Hypertension
This item provides a clinical trial update about community-based microalbuminuria screening in patients with hypertension.
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: Improving Albuminuria Screening Compliance Using a Smartphone Urinalysis Kit [NA]
A completed clinical trial evaluated whether a smartphone urinalysis kit improves albuminuria screening compliance in patients at risk for k…
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study [NA]
A pilot trial evaluating methods to control blood pressure in treatment-resistant hypertension has completed.
-
FDA approval · 2018-07-23FDA Approved: NADOLOL — Original Application (UNICHEM PHARMACEUTICALS (USA), INC.)
FDA approved Nadolol as an original application from Unichem Pharmaceuticals (USA), Inc., establishing a generic nadolol product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-07-20FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Avalide (irbesartan and hydrochlorothiazide) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2018-07-20FDA Approved: AVAPRO — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for AVAPRO (irbesartan) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Nighttime Valsartan in Hemodialysis Hypertension [Phase 4]
Phase 4 clinical trial update examining nighttime valsartan for hypertension in patients undergoing hemodialysis.
-
FDA approval · 2018-07-19FDA Approved: QUINAPRIL — Supplemental Application (BluePoint Laboratories)
FDA has approved a supplemental application for Quinapril submitted by BluePoint Laboratories. The action updates the regulatory status of t…
-
FDA approval · 2018-07-18FDA Approved: SPIRONOLACTONE — Original Application (Zydus Lifesciences Limited)
FDA approved the Original Application (ANDA) for spironolactone from Zydus Lifesciences Limited, marking a generic version of the diuretic.
-
CLINICAL_TRIALS research · 2018-07-18Clinical Trial Update: H-Type Hypertension Precision Medicine Trial [Phase 4]
This update reports a Phase 4 clinical trial for H-Type hypertension with precision medicine, sponsored by Shenzhen Ausa Pharmed Co., Ltd; t…
-
CLINICAL_TRIALS research · 2018-07-18Clinical Trial Update: Effects of Aerobic Exercise on Blood Pressure Levels of Resistant Hypertensive Subjects [NA]
This clinical trial update reports on a study examining the effects of aerobic exercise on blood pressure in resistant hypertension, with th…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Effect of Mantra on Hypertensive Patients [NA]
A completed clinical trial evaluating the drug Mantra in patients with hypertension (high blood pressure) has been reported.
-
FDA approval · 2018-07-13FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's VERAPAMIL HYDROCHLORIDE as an original ANDA generic product.
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Check and Support -Enhancing the Treatment of Hypertension in Outpatient Care, a Multicenter Study [NA]
A multicenter outpatient hypertension treatment study sponsored by Kuopio University Hospital has completed. The update notes the study stat…
-
CLINICAL_TRIALS research · 2018-07-10Clinical Trial Update: Cut Your Pressure Too: The Los Angeles Barbershop Blood Pressure Study [NA]
This update notes the completion of the Los Angeles Barbershop Blood Pressure Study, a clinical trial exploring barber shop–based interventi…
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Use of Low-cost mHealth Intervention to Enhance Outcomes of Noncommunicable Diseases Care in Rural and Refugee Settings [NA]
The study assesses a low-cost mobile health intervention to improve care outcomes for diabetes mellitus and hypertension in rural and refuge…
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Minding GOALS: An Internet-Assisted Mind-Body-Behavior Program for Blood Pressure Control [NA]
A clinical trial evaluating an internet-assisted mind-body-behavior program for blood pressure control has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of the Telmisartan/Amlodipine/Rosuvastatin combination in patients with dyslipid…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Clinical Trial of Protein and Blood Pressure [NA]
A completed clinical trial update for a study investigating protein and blood pressure in hypertension and hypercholesterolemia; results pos…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Fixed-Free HTN Trial [Phase 4]
Phase 4 clinical trial update for a hypertension study titled 'Fixed-Free HTN Trial' with the current status not disclosed.
-
FDA approval · 2018-06-29FDA Approved: NIFEDIPINE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for Nifedipine from Zydus Lifesciences Limited, a generic calcium channel blocker used for hypertensio…
-
CLINICAL_TRIALS research · 2018-06-29Clinical Trial Update: Health Impacts of a Climate Change Adaptation Strategy to Address Drinking-water Salinity in Coastal Bangladesh [NA]
An update on a clinical study assessing the health effects of a climate change adaptation strategy addressing drinking-water salinity in coa…
-
FDA approval · 2018-06-29FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original application for Triamterene and Hydrochlorothiazide from Zydus Pharmaceuticals (USA) Inc., a generic fixed-dose co…
-
FDA approval · 2018-06-29FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approved the original ANDA for olmesartan medoxomil, a generic angiotensin II receptor blocker for hypertension. The approval confirms a…